Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Mechanisms of neurocognitive dysfunction and therapeutic considerations in tuberous sclerosis complex.

Tsai P, Sahin M.

Curr Opin Neurol. 2011 Apr;24(2):106-13. doi: 10.1097/WCO.0b013e32834451c4. Review.

2.

From genes to cognition in tuberous sclerosis: implications for mTOR inhibitor-based treatment approaches.

Ehninger D.

Neuropharmacology. 2013 May;68:97-105. doi: 10.1016/j.neuropharm.2012.05.015. Epub 2012 May 22. Review.

PMID:
22626986
3.

Targeted treatments for cognitive and neurodevelopmental disorders in tuberous sclerosis complex.

de Vries PJ.

Neurotherapeutics. 2010 Jul;7(3):275-82. doi: 10.1016/j.nurt.2010.05.001. Review.

4.

Targeted treatment trials for tuberous sclerosis and autism: no longer a dream.

Sahin M.

Curr Opin Neurobiol. 2012 Oct;22(5):895-901. doi: 10.1016/j.conb.2012.04.008. Epub 2012 May 4. Review.

5.

Complex Neurological Phenotype in Mutant Mice Lacking Tsc2 in Excitatory Neurons of the Developing Forebrain(123).

Crowell B, Lee GH, Nikolaeva I, Dal Pozzo V, D'Arcangelo G.

eNeuro. 2015 Oct 22;2(6). pii: ENEURO.0046-15.2015. doi: 10.1523/ENEURO.0046-15.2015. eCollection 2015 Nov-Dec.

6.

Tuberous sclerosis--A model for tumour growth.

Dodd KM, Dunlop EA.

Semin Cell Dev Biol. 2016 Apr;52:3-11. doi: 10.1016/j.semcdb.2016.01.025. Epub 2016 Jan 24. Review.

PMID:
26816112
7.

Loss of Tsc2 in radial glia models the brain pathology of tuberous sclerosis complex in the mouse.

Way SW, McKenna J 3rd, Mietzsch U, Reith RM, Wu HC, Gambello MJ.

Hum Mol Genet. 2009 Apr 1;18(7):1252-65. doi: 10.1093/hmg/ddp025. Epub 2009 Jan 15.

8.

Translational research: Rett syndrome and tuberous sclerosis complex.

Khwaja OS, Sahin M.

Curr Opin Pediatr. 2011 Dec;23(6):633-9. doi: 10.1097/MOP.0b013e32834c9251. Review.

9.

The role of mTOR signalling in neurogenesis, insights from tuberous sclerosis complex.

Tee AR, Sampson JR, Pal DK, Bateman JM.

Semin Cell Dev Biol. 2016 Apr;52:12-20. doi: 10.1016/j.semcdb.2016.01.040. Epub 2016 Feb 2. Review.

PMID:
26849906
10.

Analysis of Proteins That Rapidly Change Upon Mechanistic/Mammalian Target of Rapamycin Complex 1 (mTORC1) Repression Identifies Parkinson Protein 7 (PARK7) as a Novel Protein Aberrantly Expressed in Tuberous Sclerosis Complex (TSC).

Niere F, Namjoshi S, Song E, Dilly GA, Schoenhard G, Zemelman BV, Mechref Y, Raab-Graham KF.

Mol Cell Proteomics. 2016 Feb;15(2):426-44. doi: 10.1074/mcp.M115.055079. Epub 2015 Sep 29.

11.

From mTOR to cognition: molecular and cellular mechanisms of cognitive impairments in tuberous sclerosis.

Ehninger D, de Vries PJ, Silva AJ.

J Intellect Disabil Res. 2009 Oct;53(10):838-51. doi: 10.1111/j.1365-2788.2009.01208.x. Epub 2009 Aug 19. Review.

12.

Mechanism-based treatment in tuberous sclerosis complex.

J├╝lich K, Sahin M.

Pediatr Neurol. 2014 Apr;50(4):290-6. doi: 10.1016/j.pediatrneurol.2013.12.002. Epub 2013 Dec 5. Review.

13.

Excitatory/inhibitory synaptic imbalance leads to hippocampal hyperexcitability in mouse models of tuberous sclerosis.

Bateup HS, Johnson CA, Denefrio CL, Saulnier JL, Kornacker K, Sabatini BL.

Neuron. 2013 May 8;78(3):510-22. doi: 10.1016/j.neuron.2013.03.017.

14.

Mammalian target of rapamycin and tuberous sclerosis complex.

Wataya-Kaneda M.

J Dermatol Sci. 2015 Aug;79(2):93-100. doi: 10.1016/j.jdermsci.2015.04.005. Epub 2015 Apr 25. Review.

PMID:
26051878
15.

Impaired Reelin-Dab1 Signaling Contributes to Neuronal Migration Deficits of Tuberous Sclerosis Complex.

Moon UY, Park JY, Park R, Cho JY, Hughes LJ, McKenna J 3rd, Goetzl L, Cho SH, Crino PB, Gambello MJ, Kim S.

Cell Rep. 2015 Aug 11;12(6):965-78. doi: 10.1016/j.celrep.2015.07.013. Epub 2015 Jul 30.

16.

The neurobiology of the tuberous sclerosis complex.

Marcotte L, Crino PB.

Neuromolecular Med. 2006;8(4):531-46. Review.

PMID:
17028374
17.

Evolving neurobiology of tuberous sclerosis complex.

Crino PB.

Acta Neuropathol. 2013 Mar;125(3):317-32. doi: 10.1007/s00401-013-1085-x. Epub 2013 Feb 6. Review.

PMID:
23386324
18.

Neuronal CTGF/CCN2 negatively regulates myelination in a mouse model of tuberous sclerosis complex.

Ercan E, Han JM, Di Nardo A, Winden K, Han MJ, Hoyo L, Saffari A, Leask A, Geschwind DH, Sahin M.

J Exp Med. 2017 Mar 6;214(3):681-697. doi: 10.1084/jem.20160446. Epub 2017 Feb 9.

19.

Tuberous sclerosis complex: a brave new world?

Ess KC.

Curr Opin Neurol. 2010 Apr;23(2):189-93. doi: 10.1097/WCO.0b013e32832c4ff5. Review.

20.

Tuberous sclerosis complex.

Islam MP, Roach ES.

Handb Clin Neurol. 2015;132:97-109. doi: 10.1016/B978-0-444-62702-5.00006-8. Review.

PMID:
26564073

Supplemental Content

Support Center